Condition: Pulmonary Hypertension · Pulmonary Vascular Disease · Left Heart Disease · Sponsor: Mayo Clinic
The goal is to compare patients with and without varying severity of pulmonary vascular disease based upon hemodynamic signatures, echocardiographic measures, and lung ultrasound, in tandem with expired gas metabolic testing and blood sampling.
This description comes directly from the study's public registry record.
Circulatory Failure Research Team · (507) 255-2200 · Fuenffinger.Annabelle@mayo.edu
Barry Borlaug, MD · (507) 255-4152 · Borlaug.Barry@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic in Rochester | Rochester, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05935605